{"id":33622,"date":"2025-05-27T09:35:18","date_gmt":"2025-05-27T07:35:18","guid":{"rendered":"https:\/\/ggba.swiss\/?p=33622"},"modified":"2025-05-27T09:35:21","modified_gmt":"2025-05-27T07:35:21","slug":"syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/","title":{"rendered":"Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices"},"content":{"rendered":"\n<p>French-Swiss company <a href=\"https:\/\/www.syrhatech.com\/\">Syrhatech<\/a> has announced the successful closing of a CHF 4.5 million financing round, backed by strategic investors. Headquartered in Plan-les-Ouates in Geneva with manufacturing operations in Chamb\u00e9ry, France, the company is a Contract Development and Manufacturing Organization (CDMO) specializing in injectable medical devices based on hyaluronic acid (HA) and other biopolymers.<\/p>\n\n\n\n<p>This new investment marks a key milestone for Syrhatech as it accelerates its expansion across both research and production. The funds will be used to strengthen its Geneva-based R&amp;D team and to install new production capacity at the Chamb\u00e9ry facility. These developments aim to meet growing global demand for injectable HA products in sectors such as aesthetic dermatology, orthopedics, and ophthalmology, with additional therapeutic areas expected to follow.<\/p>\n\n\n\n<p>Founded in 2015, Syrhatech has emerged as a key player in Europe\u2019s medical device landscape, thanks to its <a href=\"https:\/\/www.syrhatech.com\/intexhya-exclusive-technology\/\">proprietary INTEXHYA technology<\/a> and a strong commitment to quality. Operating under ISO 13485 certification, the company offers end-to-end development services, from formulation and analytical testing to sterile manufacturing. Recent investments in advanced infrastructure, including the installation of a new autoclave, further underline Syrhatech\u2019s readiness for industrial scale-up.<\/p>\n\n\n\n<p>This funding round also presents an opportunity for investors to support a high-potential company at the intersection of biotechnology and medtech. As demand for HA-based injectable products continues to rise, driven by demographic shifts and innovation in therapeutic applications, Syrhatech is well positioned to capitalize on the trend through both its scientific expertise and manufacturing agility.<\/p>\n\n\n\n<p>With this financing, Syrhatech strengthens its position as a European innovation hub for injectable biomaterials. By expanding both its Geneva and Chamb\u00e9ry sites, the company reinforces the cross-border dynamics of Western Switzerland\u2019s life sciences ecosystem and exemplifies the region\u2019s ability to foster agile, export-ready medtech companies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&#038;D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.<\/p>\n","protected":false},"author":6,"featured_media":33623,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[946,894,890,929,963,926],"class_list":["post-33622","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-additive-manufacturing","tag-financing","tag-healthcare","tag-manufacturing","tag-medical-devices","tag-medtech"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Syrhatech raises CHF 4.5 million to innovate in medical devices<\/title>\n<meta name=\"description\" content=\"Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&amp;D and manufacturing of injectable hyaluronic acid-based medical devices.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syrhatech raises CHF 4.5 million to innovate in medical devices\" \/>\n<meta property=\"og:description\" content=\"Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&amp;D and manufacturing of injectable hyaluronic acid-based medical devices.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-27T07:35:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T07:35:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices\",\"datePublished\":\"2025-05-27T07:35:18+00:00\",\"dateModified\":\"2025-05-27T07:35:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\"},\"wordCount\":305,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg\",\"keywords\":[\"Additive Manufacturing\",\"Financing\",\"Healthcare\",\"Manufacturing\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\",\"url\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\",\"name\":\"Syrhatech raises CHF 4.5 million to innovate in medical devices\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg\",\"datePublished\":\"2025-05-27T07:35:18+00:00\",\"dateModified\":\"2025-05-27T07:35:21+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Syrhatech\u2019s CHF 4.5 million raise will accelerate its R&D and production of injectable medical devices based on hyaluronic acid from Geneva and Chamb\u00e9ry. | \u00a9 Syrhatech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syrhatech raises CHF 4.5 million to innovate in medical devices","description":"Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/","og_locale":"en_US","og_type":"article","og_title":"Syrhatech raises CHF 4.5 million to innovate in medical devices","og_description":"Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices.","og_url":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-05-27T07:35:18+00:00","article_modified_time":"2025-05-27T07:35:21+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices","datePublished":"2025-05-27T07:35:18+00:00","dateModified":"2025-05-27T07:35:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/"},"wordCount":305,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg","keywords":["Additive Manufacturing","Financing","Healthcare","Manufacturing","Medical Devices","Medtech"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/","url":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/","name":"Syrhatech raises CHF 4.5 million to innovate in medical devices","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg","datePublished":"2025-05-27T07:35:18+00:00","dateModified":"2025-05-27T07:35:21+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/05\/Syrahtech-1180x811-1.jpeg","width":1180,"height":811,"caption":"Syrhatech\u2019s CHF 4.5 million raise will accelerate its R&D and production of injectable medical devices based on hyaluronic acid from Geneva and Chamb\u00e9ry. | \u00a9 Syrhatech"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/syrhatech-raises-chf-4-5-million-to-innovate-in-hyaluronic-acid-medical-devices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/33622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=33622"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/33622\/revisions"}],"predecessor-version":[{"id":33626,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/33622\/revisions\/33626"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/33623"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=33622"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=33622"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=33622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}